Currently out of the existing stock ratings of Edwin Zhang, 7 are a BUY (100%).

Edwin Zhang

Work Performance Price Targets & Ratings Chart

Analyst Edwin Zhang, carries an average stock price target met ratio of 33.33% that have a potential upside of 27.5% achieved within 96 days. Previously, Edwin Zhang worked at HC WAINWRIGHT.

Edwin Zhang’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CALT, Calliditas Therapeutics at 27-Dec-2021.

Wall Street Analyst Edwin Zhang

Analyst best performing recommendations are on LMNL (LIMINAL BIOSCIENCES).
The best stock recommendation documented was for LMNL (LIMINAL BIOSCIENCES) at 2/18/2021. The price target of $11 was fulfilled within 288 days with a profit of $51.9 (82.51%) receiving and performance score of 2.86.

Average potential price target upside

LMNL Liminal BioSciences ALDX Aldeyra The CALT Calliditas Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Feb-2021

$11

5 years 3 months 17 days ago
(24-Jun-2021)

1/1 (100%)

$-51.9 (-82.51%)

288

Buy Since 21-Dec-2020

$45

$36.5 (429.41%)

$22

5 years 4 months 9 days ago
(02-Jun-2021)

2/2 (100%)

$1.6 (3.69%)

123

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?